Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug
Tuesday, August 31, 2021
Comment
2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.
from NDTV Profit - Latest https://ift.tt/38rpZdn
from NDTV Profit - Latest https://ift.tt/38rpZdn
0 Response to "Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug"
Post a Comment